sur INNATE PHARMA (EPA:IPH)
Innate Pharma announces its participation in upcoming investor conferences
Innate Pharma SA, a publicly traded biopharmaceutical company, announced that several of its executives will participate in investor conferences in June 2024. Hervé Brailly, Sonia Quaratino, Yannis Morel and Arvind Sood will represent the company at these international events.
The conference schedule includes the Jefferies Global Healthcare Conference in New York June 5-6, and the Goldman Sachs 45th Annual Global Healthcare Conference in Miami June 10-13. Virtual participation is planned for the HC Wainwright 2nd Annual Immune Cell Engager Conference on June 25. Finally, the team will be present at the Stifel 2nd European Healthcare Summit in Lyon from June 25 to 27.
These conferences are strategic opportunities for Innate Pharma to present its innovations in immunotherapy and to strengthen relationships with investors and industrial partners.
R. E.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de INNATE PHARMA